**Cumulative influenza-associated hospitalization rates tracked by CDC FluSurv-NET have risen steadily through spring 2026 but show clear signs of plateauing as seasonal activity reaches minimal levels.** By Week 22 (ending June 6), the weekly rate stood at just 0.1 per 100,000 population with only 0.9% positivity in clinical labs, 1.4% ILI visits, and 0.2% flu-coded ED visits, consistent with off-season patterns after a moderately severe 2025–2026 season that produced a cumulative rate of 87.5 per 100,000. With Week 24 falling in mid-June, additional hospitalizations are expected to remain negligible, keeping the final cumulative figure near current levels around 87–88. Historical data show rates typically add less than 1 per 100,000 after May, supporting tight clustering among the 80–95 ranges. Model ensembles from FluSight and recent surveillance confirm the downward trajectory with no late resurgence signals, though minor reporting lags or isolated clusters could produce small upward revisions. Traders appear to weigh these low-activity dynamics against the precise final tally, producing closely matched probabilities across adjacent bins. Upcoming Week 23–24 FluView releases will provide the decisive data points for resolution.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoFlu Hospitalization Rate Week 24, 2026?
Flu Hospitalization Rate Week 24, 2026?
85–90 100%
<80 <1%
80–85 <1%
90–95 <1%
$4,630 Wol.
$4,630 Wol.
Jun 26, 2026
<80
No
80–85
No
85–90
Yes
90–95
No
95–100
No
100+
No
85–90 100%
<80 <1%
80–85 <1%
90–95 <1%
$4,630 Wol.
$4,630 Wol.
Jun 26, 2026
<80
$504 Wol.
No
80–85
$863 Wol.
No
85–90
$2,026 Wol.
Yes
90–95
$377 Wol.
No
95–100
$503 Wol.
No
100+
$357 Wol.
No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**Cumulative influenza-associated hospitalization rates tracked by CDC FluSurv-NET have risen steadily through spring 2026 but show clear signs of plateauing as seasonal activity reaches minimal levels.** By Week 22 (ending June 6), the weekly rate stood at just 0.1 per 100,000 population with only 0.9% positivity in clinical labs, 1.4% ILI visits, and 0.2% flu-coded ED visits, consistent with off-season patterns after a moderately severe 2025–2026 season that produced a cumulative rate of 87.5 per 100,000.
With Week 24 falling in mid-June, additional hospitalizations are expected to remain negligible, keeping the final cumulative figure near current levels around 87–88. Historical data show rates typically add less than 1 per 100,000 after May, supporting tight clustering among the 80–95 ranges. Model ensembles from FluSight and recent surveillance confirm the downward trajectory with no late resurgence signals, though minor reporting lags or isolated clusters could produce small upward revisions.
Traders appear to weigh these low-activity dynamics against the precise final tally, producing closely matched probabilities across adjacent bins. Upcoming Week 23–24 FluView releases will provide the decisive data points for resolution.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Rynek otwarty: Jun 21, 2026, 2:07 PM ET
Wolumen
$4,630Data zakończenia
Jun 26, 2026Rynek otwarty
Jun 21, 2026, 2:07 PM ETRozstrzygający
0x69c47de9d...Wynik zaproponowany: No
Brak sporu
Ostateczny wynik: No
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.**Cumulative influenza-associated hospitalization rates tracked by CDC FluSurv-NET have risen steadily through spring 2026 but show clear signs of plateauing as seasonal activity reaches minimal levels.** By Week 22 (ending June 6), the weekly rate stood at just 0.1 per 100,000 population with only 0.9% positivity in clinical labs, 1.4% ILI visits, and 0.2% flu-coded ED visits, consistent with off-season patterns after a moderately severe 2025–2026 season that produced a cumulative rate of 87.5 per 100,000.
With Week 24 falling in mid-June, additional hospitalizations are expected to remain negligible, keeping the final cumulative figure near current levels around 87–88. Historical data show rates typically add less than 1 per 100,000 after May, supporting tight clustering among the 80–95 ranges. Model ensembles from FluSight and recent surveillance confirm the downward trajectory with no late resurgence signals, though minor reporting lags or isolated clusters could produce small upward revisions.
Traders appear to weigh these low-activity dynamics against the precise final tally, producing closely matched probabilities across adjacent bins. Upcoming Week 23–24 FluView releases will provide the decisive data points for resolution.
This market will resolve according to the cumulative influenza-associated hospitalization rate per 100,000 population for the United States, as reported for the specified week.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
If the recorded data falls exactly between two brackets, this market will resolve to the higher bracket.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
Note: Only the CDC FluSurv-NET cumulative hospitalization rate per 100,000 population for the specified week will qualify, regardless of estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Wolumen
$4,630Data zakończenia
Jun 26, 2026Rynek otwarty
Jun 21, 2026, 2:07 PM ETRozstrzygający
0x69c47de9d...Wynik zaproponowany: No
Brak sporu
Ostateczny wynik: No
**Cumulative influenza-associated hospitalization rates tracked by CDC FluSurv-NET have risen steadily through spring 2026 but show clear signs of plateauing as seasonal activity reaches minimal levels.** By Week 22 (ending June 6), the weekly rate stood at just 0.1 per 100,000 population with only 0.9% positivity in clinical labs, 1.4% ILI visits, and 0.2% flu-coded ED visits, consistent with off-season patterns after a moderately severe 2025–2026 season that produced a cumulative rate of 87.5 per 100,000. With Week 24 falling in mid-June, additional hospitalizations are expected to remain negligible, keeping the final cumulative figure near current levels around 87–88. Historical data show rates typically add less than 1 per 100,000 after May, supporting tight clustering among the 80–95 ranges. Model ensembles from FluSight and recent surveillance confirm the downward trajectory with no late resurgence signals, though minor reporting lags or isolated clusters could produce small upward revisions. Traders appear to weigh these low-activity dynamics against the precise final tally, producing closely matched probabilities across adjacent bins. Upcoming Week 23–24 FluView releases will provide the decisive data points for resolution.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano
Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania